Tango Therapeutics Q4 EPS $(0.29) Beats $(0.33) Estimate
Tango Therapeutics (NASDAQ:TNGX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.33) by 11.04 percent. This is a 9.38 percent increase over losses of $(0.32) per share from